个人信息(Personal Information

姓名Name   张新佶Xinji Zhang 性别Gender Female
出生年月Birthday 1986.09 学位Degree 博士Ph.D
电子邮件Email xinjizhang@hotmail.com 电话Tel. 81871443
外语Foreign 英语六级CET-6 职称Job Title 讲师Lecturer

 

教育(Education

时间Time   学校University 专业Field 学位Degree
2003.09-2007.06     中国药科大学     China Pharmaceutical University 信息管理与信息系统Information Management and Information System 学士Bachelor
2007.09-2012.06    第二军医大学    Secondary Military Medical University 流行病与卫生统计学Epidemiology and  Health Statistician  博士Ph.D

 

培训(Training

时间Time   地点Location 内容Details
2008.12 世界卫生组织热带病研究中心WHO Tropical Diseases Research Center  公共卫生事业中的产品研发   Diploma Course on Research & Development of Products to Meet Public Health Needs
2009.04 世界卫生组织热带病研究中心WHO Tropical Diseases Research Center 临床数据管理软件Promasys高级培训Senior training of Promasys for clinical data management
2010.04 世界卫生组织热带病研究中心WHO Tropical Diseases Research Center            项目管理            Project management
2010.08 第二军医大学及罗氏制药公司Secondary military medical university&Roche        临床试验数据管理培训          Clinical data management training
2011.08 第二军医大学及罗氏制药公司Secondary military medical university&Roche        临床SAS应用培训             SAS programming training in clinical trials

 

代表性论著(Main Papers

  1. Zhang X, Zang J, Xu J, Bai C, Qin Y, Liu K, Wu C, Wu M, He Q, Zhang S, Wei L, He J. Maintenance therapy with continuous or switch strategy in advanced non-small-cell lung cancer: A systematic review and meta-analysis. Chest. 2011 Jul; 140(1):117-26. (IF=6.519)
  2. Zhang X, Xu J, He J. Assessing non-inferiority with time-to-event data via the method of non-parametric covariance. Statistical Methods in Medical Research 2011, DOI: 10.1177/0962280211402261. (IF=2.569)
  3. 张新佶,贺江南,任建玲等. 阳性药对照临床试验中非劣效性检验的统计分析方法及相关问题. 数理统计与管理 2010,2(23):372-379.
  4. Zhang X, Qin Y, Li H, et al. The efficacy and safety of vandetanib, a dual VEGFR and EGFR inhibitor, in advanced non-small-cell lung cancer: a systematic review and meta-analysis.  Asian Pacific Journal of Cancer Prevention 2011, 12: 2857-2863. (IF=1.24)
  5. Zhang X, Li Y, Qin Y, Li H, et al. Combined EGFR and VEGFR versus Single EGFR Signaling Pathways Inhibition Therapy for NSCLC:A Systematic Review and Meta-Analysis. PLoS ONE 2012, 7(8): e40178. doi:10.1371/journal.pone.0040178. (IF=4.411)
  6. Xie F, Zhang X, Li H, Zheng T, Xu F, et al. Adoptive Immunotherapy in Postoperative Hepatocellular Carcinoma: A Systemic Review. PLoS ONE 2012, 7(8): e42879. doi:10.1371/journal.pone.0042879. (IF=4.411)
  7. Zhang X, Lu J, Xu J, et al. Pemetrexed plus platinum versus gemcitabine plus platinum for advanced non-small-cell lung cancer: final survival analysis of a multicenter randomized phase II trial in the East Asia region and a meta-analysis. Respirology 2012, accept. (IF=1.85)
  1. Ye X, Liu H, Wu C, Qin Y, Zang J, Gao Q. Zhang X, He J. Proton pump inhibitor therapy and risk of hip fracture: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology. Eur J Gastroenterol Hepatol. 2011 Sep; 23(9):794-800. (IF=1.66)
  2. Qin Y, Li H, Gao X, Ye X, Wei X, Zhou Y, Zhang X, Wang C, Qian W, Lu Jian, He J. Adjuvant Chemotherapy, with or without Taxanes, in Early or Operable Breast Cancer: a Meta-analysis of 19 Randomized Trials with 30698 Patients. PloS ONE 2011, accepted. (IF=4.411)
  3. 贺江南, 陆健, 张新佶, 谢之辉, 贺佳.非参数模型在以等级资料为终点的非劣效性临床试验中的应用及SAS实现.中国卫生统计 2009, 29(5):516-518.
  4. 贺江南, 张新佶, 谢之辉, 吴美京, 贺佳. 正态分布资料等效性评价的传统假设检验方法与贝叶斯方法比较.中国卫生统计 2009, 26(4):422-425.

 

 

参编著作(Works

时间   书名 出版社
2012 医学统计学 高等教育出版社
2012 临床试验设计与统计分析 人民卫生出版社